Immunologic diagnosis of Legionnaires' disease: cross-reactions with anaerobic and microaerophilic organisms and infections caused by them

The Journal of Infectious Diseases
P H EdelsteinS M Finegold

Abstract

The hundred twenty-four isolates of anaerobic and microaerophilis organisms were examined with a polyvalent direct immunofluorescent antibody (DFA) reagent directed against Legionella pneumophila, serogroups (SG) I-IV. Three of 53 isolates of Bacteroides fragilis cross-reated with the SG I component of the reagent. Rabbit antisera to three SG I strains of L. pneumophila cross-reacted with these three B. fragilis isolates, and cross-reactivity was not due to preexisting rabbit antibodies; antisera to a fourth SG I strain did not cross-react with these isolates. Indirect fluorescent antibody (IFA) examinations of convalescent-phase sera from eight of 41 patients with B. fragilis group infections showed titers of greater than or equal to 1:128 or a fourfold or greater seroconversion against L. pneumophila, SG I. All eight patients had bacteremia due to B. fragilis, but five B. fragilis isolates available from these patients were DFA-negative. Thus, false-positive reactions may result from DFA as well as IFA examinations of sera from patients with B. fragilis infections.

Citations

Jan 1, 1984·European Journal of Pediatrics·P BeyerB Weber
Jun 1, 1984·European Journal of Clinical Microbiology·Y GlupczynskiE Yourassowsky
Feb 1, 1987·European Journal of Clinical Microbiology·P H Edelstein
Feb 1, 1988·Diagnostic Microbiology and Infectious Disease·D J FlournoyP J Guthrie
Jan 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A PhakkeyB P Berdal
Jul 5, 2002·Clinical Microbiology Reviews·Barry S FieldsRichard E Besser
Mar 6, 2009·Journal of Clinical Microbiology·Hsun-Pi SuTsung Chain Chang
Jan 31, 2012·International Journal of Microbiology·Tatiana C TravisBarry S Fields
Jan 18, 1992·Lancet·T C Boswell, G Kudesia
Sep 18, 2007·Paediatric Respiratory Reviews·Joshua Wolf, Andrew J Daley
Sep 1, 1985·Chest·R L Ristagno, L D Saravolatz
Feb 1, 1988·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·J M BangsborgK Lind
Apr 17, 2001·Scandinavian Journal of Infectious Diseases·J DarelidA M Olinder-Nielsen
Aug 1, 1983·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology·K Lind
Nov 1, 1983·Journal of Clinical Microbiology·J A Bridge, P H Edelstein
Dec 1, 1984·Journal of Clinical Microbiology·L H GostingL C Goldstein
Jan 1, 1981·Journal of Clinical Microbiology·H W WilkinsonC V Broome
Jan 1, 1988·Clinical Microbiology Reviews·W C Winn
Apr 1, 1987·Journal of Clinical Microbiology·R F BensonH W Wilkinson
Mar 1, 1986·Journal of Clinical Microbiology·P H Edelstein
Feb 1, 1986·Journal of Clinical Microbiology·H W WilkinsonB B Plikaytis
Jan 1, 1982·Journal of Clinical Microbiology·M T CollinsJ S Reif
Apr 1, 1982·The American Journal of Medicine·B SathapatayavongsP H Edelstein
Jan 1, 1982·La Revue de médecine interne·B Becq-GiraudonY Sudre
Apr 1, 1991·American Journal of Infection Control·T J MarrieD Haldane
Jun 1, 1994·Chest·J RoigJ Morera

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.